In some of the cases, both mRNA and protein levels of RNF4 are elevated in human cancer cells, which potentiates the tumorigenic properties of cancer cells, and correlates with poor prognosis and with resistance to anticancer agents [26,29]. This evidence concerns the gene RNF4 and cancer.